BioBag Zenzo A/S — Credit Rating and Financial Key Figures
CVR number: 26899931
Frydenborgvej 27 D, 3400 Hillerød
zenzo@zenzo.dk
tel: 70271900
www.zenzo.dk
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 4 221.09 | 3 815.29 | 4 471.52 | 5 601.59 | 6 289.73 |
| Employee benefit expenses | -4 069.26 | -3 312.50 | -3 373.69 | -3 346.66 | -3 492.52 |
| EBIT | 151.83 | 502.79 | 1 097.82 | 2 254.93 | 2 797.21 |
| Other financial income | 48.08 | 36.72 | |||
| Other financial expenses | -40.40 | -36.51 | -55.09 | -55.94 | -52.80 |
| Pre-tax profit | 111.44 | 466.28 | 1 042.73 | 2 247.07 | 2 781.13 |
| Income taxes | -24.59 | - 103.77 | - 231.64 | - 494.34 | - 647.94 |
| Net earnings | 86.84 | 362.51 | 811.09 | 1 752.73 | 2 133.19 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Other receivables | 93.09 | 95.32 | 97.23 | 101.12 | 104.72 |
| Investments total | 93.09 | 95.32 | 97.23 | 101.12 | 104.72 |
| Long term receivables total | |||||
| Finished products/goods | 247.25 | 191.09 | 138.71 | 187.07 | 283.51 |
| Inventories total | 247.25 | 191.09 | 138.71 | 187.07 | 283.51 |
| Current trade debtors | 1 493.88 | 3 891.87 | 5 236.84 | 8 381.47 | 3 399.86 |
| Current amounts owed by group member comp. | 111.91 | 19.84 | 4 230.73 | 8 571.69 | |
| Prepayments and accrued income | 122.97 | 57.02 | 8.12 | 80.32 | |
| Current other receivables | 136.53 | 59.33 | 1.38 | ||
| Current deferred tax assets | 154.00 | 154.00 | 140.94 | ||
| Short term receivables total | 1 865.28 | 4 008.22 | 5 410.68 | 12 774.32 | 12 194.18 |
| Cash and bank deposits | 4 249.89 | 5 849.03 | 2 490.86 | 757.93 | 240.74 |
| Cash and cash equivalents | 4 249.89 | 5 849.03 | 2 490.86 | 757.93 | 240.74 |
| Balance sheet total (assets) | 6 455.50 | 10 143.66 | 8 137.48 | 13 820.45 | 12 823.16 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Shares repurchased | 1 500.00 | 2 300.00 | |||
| Retained earnings | 1 684.50 | 1 771.35 | 2 133.86 | 1 444.95 | 897.67 |
| Profit of the financial year | 86.84 | 362.51 | 811.09 | 1 752.73 | 2 133.19 |
| Shareholders equity total | 2 171.35 | 2 533.86 | 3 344.95 | 5 097.67 | 5 730.87 |
| Provisions | 565.00 | 1 100.00 | 1 100.00 | 640.63 | |
| Non-current other liabilities | 268.19 | ||||
| Non-current liabilities total | 268.19 | ||||
| Advances received | 621.95 | 192.50 | |||
| Current trade creditors | 758.24 | 645.40 | 815.32 | 2 243.97 | 1 334.31 |
| Current owed to group member | 42.82 | 297.07 | 133.48 | 1 429.79 | 545.92 |
| Other non-interest bearing current liabilities | 3 214.91 | 5 480.39 | 2 743.73 | 3 756.51 | 4 571.44 |
| Current liabilities total | 4 015.97 | 7 044.80 | 3 692.53 | 7 622.77 | 6 451.67 |
| Balance sheet total (liabilities) | 6 455.50 | 10 143.66 | 8 137.48 | 13 820.45 | 12 823.16 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.